We also assessed the expression of Dlx-2 protein in human tumors, including breast, colon, and ovarian cancers, with immunohistochemical staining (IHC) in paraffin-embedded and formalin-fixed tissues and compared the results with those of real-time PCR analysis (Figure 3). This evidence concerns the gene DLX2 and ovarian cancer.